Diagnostic Approaches for Large Vessel Vasculitides

References

• Jennette J, Falk R, Bacon P, et al. 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65(1):1–11. doi:10.1002/art.37715
   PubMed Web of Science ®Google Scholar
• Castelein T, Coudyzer W, Blockmans D. IgG4-related periaortitis vs idiopathic periaortitis: is there a role for atherosclerotic plaque in the pathogenesis of IgG4-related periaortitis? Rheumatology (Oxford). 2015;54(7):1250–1256.
   Web of Science ®Google Scholar
• Hall S, Lie JT, Kurland LT, Persellin S, O’Brien PC, Hunder GG. The therapeutic impact of temporal artery biopsy. Lancet. 1983;322(8361):1217–1220.
   Google Scholar
• Dejaco C, Ramiro S, Duftner C, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis. 2018;77(5):636–643.
   PubMed Web of Science ®Google Scholar
• van der Geest KSM, Sandovici M, Brouwer E, Mackie SL. Diagnostic accuracy of symptoms, physical signs, and laboratory tests for giant cell arteritis: a systematic review and meta-analysis. JAMA Intern Med. 2020;180(10):1295–1304.
   Web of Science ®Google Scholar
• Kim ESH, Beckman J. Takayasu arteritis: challenges in diagnosis and management. Heart. 2018;104(7):558–565.
   PubMed Web of Science ®Google Scholar
• Weyand CM, Goronzy JJ. Medium-and large-vessel vasculitis. N Engl J Med. 2003;349(2):160–169.
   PubMed Web of Science ®Google Scholar
• Weyand CM, Goronzy JJ. Giant-cell arteritis and polymyalgia rheumatica. N Engl J Med. 2014;371(1):50–57. doi:10.1056/NEJMcp1214825
   PubMed Web of Science ®Google Scholar
• Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis. Ann Intern Med. 1994;120(11):919–929.
   PubMed Web of Science ®Google Scholar
• Quinn KA, Gribbons KB, Carette S, et al. Patterns of clinical presentation in Takayasu’s arteritis. Semin Arthritis Rheum. 2020;50(4):576–581. doi:10.1016/j.semarthrit.2020.04.012
   Web of Science ®Google Scholar
• Marvisi C, Buttini EA, Vaglio A Aortitis and periaortitis: the puzzling spectrum of inflammatory aortic diseases. Presse Med 2020:104018.
   Google Scholar
• Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet. 2006;367(9506):241–251. doi:10.1016/S0140-6736(06)68035-5
   PubMed Web of Science ®Google Scholar
• Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 2010;33(8):1122–1128. doi:10.1002/art.1780330810
   Google Scholar
• Tuckwell K, Collinson N, Klearman M, Dimonaco S, Stone JH, Investigators G. Classification criteria for giant cell arteritis: data from giacta informing the need for revision. Ann Rheum Dis. 2016;75:571.
   Web of Science ®Google Scholar
• de Boysson H, Liozon E, Ly KH, Dumont A, Delmas C, Aouba A. The different clinical patterns of giant cell arteritis. Clin Exp Rheumatol. 2019;37 Suppl 1(2):57–60.
   Web of Science ®Google Scholar
• Seeliger B, Sznajd J, Robson JC, et al. Are the 1990 American College of Rheumatology vasculitis classification criteria still valid? Rheumatology (Oxford). 2017;56(7):1154–1161.
   PubMed Web of Science ®Google Scholar
• Ksm VDG, Borg F, Kayani A, et al. Novel ultrasonographic Halo Score for giant cell arteritis: assessment of diagnostic accuracy and association with ocular ischaemia. Ann Rheum Dis. 2020;79(3):393–399.
   Web of Science ®Google Scholar
• Ponte C, Grayson PC, Suppiah R, et al. Development of the Classification Criteria for GIANT Cell Arteritis in the Diagnostic and Classification Criteria for Vasculitis Study: a Pilot Study Using A Panel Review Methodology. Ann Rheum Dis. 2014;73(2):555.
   Google Scholar
• Aws DS, de Carvalho JF. Diagnostic and classification criteria of Takayasu arteritis. J Autoimmun. 2014;48:79–83.
   Web of Science ®Google Scholar
• Jennette JC, Falk RJ. The role of pathology in the diagnosis of systemic vasculitis. Clin Exp Rheumatol. 2007;25(1 Suppl 44):S52–6.
   Web of Science ®Google Scholar
• Galli E, Muratore F, Boiardi L, et al. Significance of inflammation restricted to adventitial/periadventitial tissue on temporal artery biopsy. Semin Arthritis Rheum. 2020;50:1064–1072.
   Web of Science ®Google Scholar
• Rubenstein E, Maldini C, Gonzalez-Chiappe S, Chevret S, Mahr A. Sensitivity of temporal artery biopsy in the diagnosis of giant cell arteritis: a systematic literature review and meta-analysis. Rheumatology. 2020;59(5):1011–1020.
   Web of Science ®Google Scholar
• Ing EB, Wang DN, Kirubarajan A, et al. Systematic review of the yield of temporal artery biopsy for suspected giant cell arteritis. Neuroophthalmology. 2019;43(1):18–25.
   PubMed Web of Science ®Google Scholar
• Taylor-Gjevre R, Vo M, Shukla D, Resch L. Temporal artery biopsy for giant cell arteritis. J Rheumatol. 2005;32(7):1279–1282.
   PubMed Web of Science ®Google Scholar
• Mahr A, Saba M, Kambouchner M, et al. Temporal artery biopsy for diagnosing giant cell arteritis: the longer, the better? Ann Rheum Dis. 2006;65(6):826–828.
   PubMed Web of Science ®Google Scholar
• Chu R, Foster C, Ali M, et al. Optimal length and usefulness of temporal artery biopsies in the diagnosis of giant cell arteritis: a 10-year retrospective review of medical records. Lancet Rheumatol. 2020;2(12): e774-e778.
   Google Scholar
• Muratore F, Boiardi L, Cavazza A, et al. Association between specimen length and number of sections and diagnostic yield of temporal artery biopsy for giant cell arteritis. Arthritis Care Res (Hoboken). 2021;73(3):402–408.
   Web of Science ®Google Scholar
• Luqmani R, Lee E, Singh S, et al. The and Treatment role of ultrasound compared to biopsy of temporal arteries in the diagnosis of Giant Cell Arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study. Health Technol Assess. 2016;20(90):1–238.
   PubMed Web of Science ®Google Scholar
• Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Arthritis Rheum. 1994;37(2):187–192.
   PubMed Web of Science ®Google Scholar
• Saadoun D, Lambert M, Mirault T, et al. Retrospective analysis of surgery versus endovascular intervention in Takayasu arteritis: a multicenter experience. Circulation. 2012;125(6):813–819.
   PubMed Web of Science ®Google Scholar
• Baril DT, Carroccio A, Palchik E, et al. Endovascular treatment of complicated aortic aneurysms in patients with underlying arteriopathies. Ann Vasc Surg. 2006;20(4):464–471.
   Web of Science ®Google Scholar
• Chrysidis S, Duftner C, Dejaco C, et al. Definitions and reliability assessment of elementary ultrasound lesions in giant cell arteritis: a study from the OMERACT Large Vessel Vasculitis Ultrasound Working Group. RMD Open. 2018;4(1):e000598.
   Web of Science ®Google Scholar
• Schmidt W, Kraft H, Völker L, Vorpahl K, Colour G-IE. Doppler sonography to diagnose temporal arteritis. Lancet. 1995;345(8953):866.
   Web of Science ®Google Scholar
• Duftner C, Dejaco C, Sepriano A, Falzon L, Schmidt WA, Ramiro S. Imaging in diagnosis, outcome prediction and monitoring of large vessel vasculitis: a systematic literature review and meta-analysis informing the EULAR recommendations. RMD Open. 2018;4(1):e000612.
   Web of Science ®Google Scholar
• Schmidt WA. Ultrasound in the diagnosis and management of giant cell arteritis. Rheumatology. 2018;57(suppl_2):ii22–ii31.
   PubMed Web of Science ®Google Scholar
• Schmidt WA, Seifert A, Gromnica-ihle E, Krause A, Natusch A. Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology. 2008;47(1):96–101.
   Web of Science ®Google Scholar
• Schmidt WA, Blockmans D. Investigations in systemic vasculitis – the role of imaging. Best Pract Res Clin Rheumatol. 2018;32(1):63–82.
   Web of Science ®Google Scholar
• Rinagel M, Chatelus E, Jousse-Joulin S, et al. Diagnostic performance of temporal artery ultrasound for the diagnosis of giant cell arteritis: a systematic review and meta-analysis of the literature. Autoimmun Rev. 2019;18(1):56–61.
   Web of Science ®Google Scholar
• Karassa FB, Matsagas MI, Schmidt WA, Ioannidis JPA. Meta-analysis: test performance of ultrasonography for giant-cell arteritis. Ann Intern Med. 2005;142(5):359–369.
   PubMed Web of Science ®Google Scholar
• Germanò G, Muratore F, Cimino L, et al. Is colour duplex sonography-guided temporal artery biopsy useful in the diagnosis of giant cell arteritis? A randomized study. Rheumatology. 2015;54(3):400–404.
   Web of Science ®Google Scholar
• van der Geest KSM, Wolfe K, Borg F, et al. Ultrasonographic Halo Score in giant cell arteritis: association with intimal hyperplasia and ischaemic sight loss. Rheumatology. 2020.
   Web of Science ®Google Scholar
• Patil P, Williams M, Maw WW, et al. Fast track pathway reduces sight loss in giant cell arteritis: results of a longitudinal observational cohort study. Clin Exp Rheumatol. 2015;33(2 Suppl 89):S-103-6.
   PubMed Web of Science ®Google Scholar
• Monti S, Bartoletti A, Bellis E, Delvino P, Montecucco C. Fast-track ultrasound clinic for the diagnosis of giant cell arteritis changes the prognosis of the disease but not the risk of future relapse. Front Med. 2020;7:589794.
   PubMed Web of Science ®Google Scholar
• Fan W, Zhu J, Li J, Zhang W, Li C. Ultrasound morphological changes in the carotid wall of Takayasu’s arteritis: monitor of disease progression. Int Angiol. 2016;35(6):586–592.
   Web of Science ®Google Scholar
• Barra L, Kanji T, Malette J, Pagnoux C. Imaging modalities for the diagnosis and disease activity assessment of Takayasu’s arteritis: a systematic review and meta-analysis. Autoimmun Rev. 2018;17(2):175–187.
   PubMed Web of Science ®Google Scholar
• Schmidt WA. Role of ultrasound in the understanding and management of vasculitis. Ther Adv Musculoskelet Dis. 2014;6(2):39–47.
   PubMedGoogle Scholar
• Czihal M, Lottspeich C, Hoffmann U. Ultrasound imaging in the diagnosis of large vessel vasculitis. Vasa. 2017;46(4):241–253.
   Web of Science ®Google Scholar
• Partovi S, Imfeld S, Aschwanden M, Bilecen D, Jaeger KA, Staub D. The use of contrast-enhanced ultrasound (CEUS) in chronic periaortitis. Ultraschall der Medizin-European J Ultrasound. 2013;34(01):2–3.
   Google Scholar
• Li X, Staub D, Rafailidis V, Al-Natour M, Kalva S, Partovi S. Contrast-enhanced ultrasound of the abdominal aorta–current status and future perspectives. Vasa. 2019;48:115–125.
   Web of Science ®Google Scholar
• Prieto-González S, Arguis P, García-Martínez A, et al. Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography. Ann Rheum Dis. 2012;71(7):1170–1176.
   PubMed Web of Science ®Google Scholar
• Prieto-González S, García-Martínez A, Tavera-Bahillo I, et al. Effect of glucocorticoid treatment on computed tomography angiography detected large-vessel inflammation in giant-cell arteritis. A prospective, longitudinal study. Medicine (Baltimore). 2015;94:5.
   Web of Science ®Google Scholar
• Lariviere D, Benali K, Coustet B, et al. Positron emission tomography and computed tomography angiography for the diagnosis of giant cell arteritis: a real-life prospective study. Medicine (Baltimore). 2016;95:30.
   Web of Science ®Google Scholar
• De Boysson H, Dumont A, Liozon E, et al. Giant-cell arteritis: concordance study between aortic CT angiography and FDG-PET/CT in detection of large-vessel involvement. Eur J Nucl Med Mol Imaging. 2017;44(13):2274–2279.
   Web of Science ®Google Scholar
• Hommada M, Mekinian A, Brillet P-Y, et al. Aortitis in giant cell arteritis: diagnosis with FDG PET/CT and agreement with CT angiography. Autoimmun Rev. 2017;16(11):1131–1137.
   Web of Science ®Google Scholar
• García-Martínez A, Arguis P, Prieto-González S, et al. Prospective long term follow-up of a cohort of patients with giant cell arteritis screened for aortic structural damage (aneurysm or dilatation). Ann Rheum Dis. 2014;73(10):1826–1832.
   Web of Science ®Google Scholar
• Park JH, Chung JW, Lee KW, Park YB, Han MC. CT angiography of Takayasu arteritis: comparison with conventional angiography. J Vasc Interv Radiol. 1997;8(3):393–400.
   Web of Science ®Google Scholar
• Zhu FP, Luo S, Wang ZJ, Jin ZY, Zhang LJ, Lu GM. Takayasu arteritis: imaging spectrum at multidetector CT angiography. Br J Radiol. 2012;85(1020):e1282–e1292.
   PubMed Web of Science ®Google Scholar
• Khandelwal N, Kalra N, Garg MK, et al. Multidetector CT angiography in Takayasu arteritis. Eur J Radiol. 2011;77(2):369–374.
   Web of Science ®Google Scholar
• Siemonsen S, Brekenfeld C, Holst B, Kaufmann-Buehler A-K, Fiehler J, Bley TA. 3T MRI reveals extra-and intracranial involvement in giant cell arteritis. Am J Neuroradiol. 2015;36(1):91–97.
   PubMed Web of Science ®Google Scholar
• Muratore F, Pipitone N, Salvarani C, Schmidt WA. Imaging of vasculitis: state of the art. Best Pract Res Clin Rheumatol. 2016;30(4):688–706.
   Web of Science ®Google Scholar
• Blockmans D, Luqmani R, Spaggiari L, Salvarani C. Magnetic resonance angiography versus 18F-fluorodeoxyglucose positron emission tomography in large vessel vasculitis. Autoimmun Rev. 2019;18(12):102405.
   Web of Science ®Google Scholar
• Bley TA, Wieben O, Uhl M, Thiel J, Schmidt D, Langer M. High-resolution MRI in giant cell arteritis: imaging of the wall of the superficial temporal artery. Am J Roentgenol. 2005;184(1):283–287.
   PubMed Web of Science ®Google Scholar
• Bley TA, Weiben O, Uhl M, et al. Assessment of the cranial involvement pattern of giant cell arteritis with 3T magnetic resonance imaging. Arthritis Rheum. 2005;52(8):2470–2477.
   PubMed Web of Science ®Google Scholar
• Yamada I, Nakagawa T, Himeno Y, Kobayashi Y, Numano F, Shibuya H. Takayasu arteritis: diagnosis with breath‐hold contrast‐enhanced three‐dimensional MR angiography. J Magn Reson Imaging. 2000;11(5):481–487.
   Web of Science ®Google Scholar
• Kamper L, Brandt AS, Ekamp H, et al. Diffusion-weighted MRI findings of treated and untreated retroperitoneal fibrosis. Diagnostic Interv Radiol. 2014;20(6):459.
   Web of Science ®Google Scholar
• Bakir B, Yilmaz F, Turkay R, et al. Role of diffusion-weighted MR imaging in the differentiation of benign retroperitoneal fibrosis from malignant neoplasm: preliminary study. Radiology. 2014;272(2):438–445.
   Web of Science ®Google Scholar
• Rosenkrantz AB, Spieler B, Seuss CR, Stifelman MD, Kim S. Utility of MRI features for differentiation of retroperitoneal fibrosis and lymphoma. Am J Roentgenol. 2012;199(1):118–126.
   Web of Science ®Google Scholar
• Prieto-González S, Espígol-Frigolé G, García-Martínez A, et al. The expanding role of imaging in systemic vasculitis. Rheum Dis Clin North Am. 2016;42(4):733–751.
   Web of Science ®Google Scholar
• Nielsen BD, Hansen IT, Kramer S, et al. Simple dichotomous assessment of cranial artery inflammation by conventional 18F-FDG PET/CT shows high accuracy for the diagnosis of giant cell arteritis: a case-control study. Eur J Nucl Med Mol Imaging. 2019;46(1):184–193.
   Web of Science ®Google Scholar
• Nienhuis PH, Sandovici M, Glaudemans AWJM, Slart RHJA, Brouwer E. Visual and semiquantitative assessment of cranial artery inflammation with FDG-PET/CT in giant cell arteritis. Semin Arthritis Rheum. 2020;50(4):616–623.
   Web of Science ®Google Scholar
• Blockmans D. Ceuninck L de, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18F‐fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Care Res (Hoboken). 2006;55(1):131–137.
   Web of Science ®Google Scholar
• Nielsen BD, Gormsen LC, Hansen IT, Keller KK, Therkildsen P, Hauge E-M. Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy. Eur J Nucl Med Mol Imaging. 2018;45(7):1119–1128.
   PubMed Web of Science ®Google Scholar
• Clifford AH, Murphy EM, Burrell SC, et al. Positron emission tomography/computerized tomography in newly diagnosed patients with giant cell arteritis who are taking glucocorticoids. J Rheumatol. 2017;44(12):1859–1866.
   Web of Science ®Google Scholar
• Robson JC, Kiran A, Maskell J, et al. The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK. Ann Rheum Dis. 2015;74(1):129–135.
   PubMed Web of Science ®Google Scholar
• Blockmans D, Coudyzer W, Vanderschueren S, et al. Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis. Rheumatology. 2008;47(8):1179–1184.
   Web of Science ®Google Scholar
• de Boysson H, Liozon E, Lambert M, et al. 18F-fluorodeoxyglucose positron emission tomography and the risk of subsequent aortic complications in giant-cell arteritis: a multicenter cohort of 130 patients. Medicine (Baltimore). 2016;95(26):e3851.
   Web of Science ®Google Scholar
• Muratore F, Crescentini F, Spaggiari L, et al. Aortic dilatation in patients with large vessel vasculitis: A longitudinal case control study using PET/CT. Semin Arthritis Rheum. 2019;48(6):1074–1082.
   Google Scholar
• Ihata A, Shizukuishi K, Kishimoto D, et al. FRI0476 Relative fdg accumulation of the aortic wall lesions to aortic blood pool in 18f-fdg-pet and pet/ct is a useful parameter for assessing the disease activity of takayasu arteritis. Ann Rheum Dis. 2013;72(Suppl 3):A536–A536.
   Google Scholar
• Sharma V, Nagaraj S, Mangat G, Balakrishnan C, Krishna B, Samant R. AB0778 Role of pet scan in the management of patients with takayasu arteritis. Ann Rheum Dis. 2013;71(Suppl 3):683.
   Google Scholar
• Alibaz-Oner F, Dede F, Ones T, Turoglu HT, Direskeneli H. Patients with Takayasu’s arteritis having persistent acute-phase response usually have an increased major vessel uptake by 18F-FDG-PET/CT. Mod Rheumatol. 2015;25(5):752–755.
   PubMed Web of Science ®Google Scholar
• Santhosh S, Mittal BR, Gayana S, Bhattacharya A, Sharma A, Jain S. F-18 FDG PET/CT in the evaluation of Takayasu arteritis: an experience from the tropics. J Nucl Cardiol. 2014;21(5):993–1000.
   PubMed Web of Science ®Google Scholar
• Lee K, Cho A, Choi Y, et al. The role of 18F‐fluorodeoxyglucose–positron emission tomography in the assessment of disease activity in patients with Takayasu arteritis. Arthritis Rheum. 2012;64(3):866–875.
   Web of Science ®Google Scholar
• Incerti E, Tombetti E, Fallanca F, et al. 18 F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu’s arteritis. Eur J Nucl Med Mol Imaging. 2017;44(7):1109–1118.
   Web of Science ®Google Scholar
• Derdelinckx I, Maes A, Bogaert J, Mortelmans L, Blockmans D. Positron emission tomography scan in the diagnosis and follow-up of aortitis of the thoracic aorta. Acta Cardiol. 2000;55(3):193–195.
   Web of Science ®Google Scholar
• Drieskens O, Blockmans D, Van den Bruel A, Mortelmans L. Riedel’s thyroiditis and retroperitoneal fibrosis in multifocal fibrosclerosis: positron emission tomographic findings. Clin Nucl Med. 2002;27(6):413–415.
   Web of Science ®Google Scholar
• Blockmans D, Baeyens H, Van Loon R, Lauwers G, Bobbaers H. Periaortitis and aortic dissection due to Wegener’s granulomatosis. Clin Rheumatol. 2000;19(2):161–164.
   Web of Science ®Google Scholar
• Salvarani C, Pipitone N, Versari A, et al. Positron emission tomography (PET): evaluation of chronic periaortitis. Arthritis Care Res (Hoboken). 2005;53(2):298–303.
   Web of Science ®Google Scholar
• Hotta M, Naka G, Minamimoto R, Takeda Y, Nivolumab-Induced Periaortitis HM. Demonstrated by FDG PET/CT. Clin Nucl Med. 2020;45(11):910–912.
   Web of Science ®Google Scholar
• Zhang J, Chen H, Ma Y, et al. Characterizing IgG4-related disease with 18 F-FDG PET/CT: a prospective cohort study. Eur J Nucl Med Mol Imaging. 2014;41(8):1624–1634.
   PubMed Web of Science ®Google Scholar
• Šteňová E, Šteňo B, Povinec P, Ondriaš F, Rampalová J. FDG-PET in the Erdheim–Chester disease: its diagnostic and follow-up role. Rheumatol Int. 2012;32(3):675–678.
   PubMed Web of Science ®Google Scholar
• Young JR, Johnson GB, Murphy RC, Go RS, Broski SM. 18F-FDG PET/CT in Erdheim–Chester Disease: imaging Findings and Potential BRAF Mutation Biomarker. J Nucl Med. 2018;59(5):774–779.
   Web of Science ®Google Scholar
• Nakatani K, Nakamoto Y, Togashi K. Utility of FDG PET/CT in IgG4-related systemic disease. Clin Radiol. 2012;67(4):297–305.
   PubMed Web of Science ®Google Scholar